Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 4
1975 1
1976 1
1977 1
1979 1
1984 1
1985 3
1986 4
1987 1
1988 4
1989 1
1990 1
1992 1
1993 2
1994 3
1997 2
1998 2
2002 2
2009 1
2010 2
2011 2
2012 1
2013 1
2014 1
2015 4
2016 5
2017 3
2018 5
2019 4
2020 6
2021 12
2022 7
2023 7
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines on clinical presentation and management of nondystrophic myotonias.
Stunnenberg BC, LoRusso S, Arnold WD, Barohn RJ, Cannon SC, Fontaine B, Griggs RC, Hanna MG, Matthews E, Meola G, Sansone VA, Trivedi JR, van Engelen BGM, Vicart S, Statland JM. Stunnenberg BC, et al. Among authors: lorusso s. Muscle Nerve. 2020 Oct;62(4):430-444. doi: 10.1002/mus.26887. Epub 2020 May 27. Muscle Nerve. 2020. PMID: 32270509 Free PMC article. Review.
Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.
Campbell CM, Baiyee CAMT, Almaani S, Bumma N, Sharma N, LoRusso S, Redder E, Bittengle J, Pfund K, Friemer M, Tong M, Kahwash R, Efebera Y, Parikh S, Vallakati A. Campbell CM, et al. Among authors: lorusso s. Am J Ther. 2023 Sep-Oct 01;30(5):e447-e453. doi: 10.1097/MJT.0000000000001296. Epub 2021 Nov 23. Am J Ther. 2023. PMID: 37713689
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial.
Tawil R, Wagner KR, Hamel JI, Leung DG, Statland JM, Wang LH, Genge A, Sacconi S, Lochmüller H, Reyes-Leiva D, Diaz-Manera J, Alonso-Perez J, Muelas N, Vilchez JJ, Pestronk A, Gibson S, Goyal NA, Hayward LJ, Johnson N, LoRusso S, Freimer M, Shieh PB, Subramony SH, van Engelen B, Kools J, Leinhard OD, Widholm P, Morabito C, Moxham CM, Cadavid D, Mellion ML, Odueyungbo A, Tracewell WG, Accorsi A, Ronco L, Gould RJ, Shoskes J, Rojas LA, Jiang JG. Tawil R, et al. Among authors: lorusso s. Lancet Neurol. 2024 May;23(5):477-486. doi: 10.1016/S1474-4422(24)00073-5. Lancet Neurol. 2024. PMID: 38631764 Clinical Trial.
Disorders of the Cauda Equina.
LoRusso S. LoRusso S. Continuum (Minneap Minn). 2021 Feb 1;27(1):205-224. doi: 10.1212/CON.0000000000000903. Continuum (Minneap Minn). 2021. PMID: 33522743 Review.
Infections of the Peripheral Nervous System.
LoRusso S. LoRusso S. Continuum (Minneap Minn). 2021 Aug 1;27(4):921-942. doi: 10.1212/CON.0000000000000981. Continuum (Minneap Minn). 2021. PMID: 34623098 Review.
Myelopathies Due to Structural Cervical and Thoracic Disease.
Stino AM, LoRusso SJ. Stino AM, et al. Among authors: lorusso sj. Continuum (Minneap Minn). 2018 Apr;24(2, Spinal Cord Disorders):567-583. doi: 10.1212/CON.0000000000000594. Continuum (Minneap Minn). 2018. PMID: 29613900 Review.
Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy.
Ramsell S, Arias Bermudez C, Takem Baiyee CAM, Rodgers B, Parikh S, Almaani S, Sharma N, LoRusso S, Freimer M, Redder E, Bumma N, Vallkati A, Efebera Y, Kahwash R, Campbell CM. Ramsell S, et al. Among authors: lorusso s. Front Cardiovasc Med. 2022 Jul 11;9:907597. doi: 10.3389/fcvm.2022.907597. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35898273 Free PMC article.
Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
Wang LH, Leung DG, Wagner KR, Lowry SJ, McDermott MP, Eichinger K, Higgs K, Walker M, Lewis L, Martens WB, Mul K, Sansone VA, Shieh P, Elsheikh B, LoRusso S, Butterfield RJ, Johnson N, Preston MR, Messina C, Carraro E, Tawil R, Statland J; ReSolve Investigators of the FSHD CTRN. Wang LH, et al. Among authors: lorusso s. Neuromuscul Disord. 2023 Sep;33(9):63-68. doi: 10.1016/j.nmd.2023.06.008. Epub 2023 Jun 21. Neuromuscul Disord. 2023. PMID: 37400350 Free PMC article.
87 results